- Tel: 858.663.9055
-
Email: info@nsjbio.com
- Tel: 858.663.9055
- Email: info@nsjbio.com
Related Products
|
Protein PML Antibody / TRIM19 Polyclonal Antibody targets promyelocytic leukemia protein (PML), also known as TRIM19, a member of the tripartite motif family that functions in nuclear organization, tumor suppression, and cellular stress responses. PML is best known for its role in forming PML nuclear bodies, specialized nuclear structures that concentrate proteins involved in transcriptional regulation, apoptosis, senescence, and genome maintenance. The protein contains a conserved RBCC motif consisting of a RING finger domain, two B-box domains, and a coiled-coil region. These structural elements mediate protein interactions and contribute to the assembly of nuclear bodies.
PML nuclear bodies function as dynamic regulatory compartments rather than membrane-bound organelles. Their formation involves PML oligomerization and post-translational modifications, particularly SUMOylation, which facilitates recruitment of proteins containing SUMO-interacting motifs. PML also undergoes phosphorylation, ubiquitination, and other modifications that influence its stability, localization, and interactions. Alternative splicing generates multiple PML isoforms with distinct C-terminal sequences, contributing to differences in nuclear distribution and biological activity. These mechanisms allow PML nuclear bodies to respond to changing cellular conditions and coordinate diverse signaling pathways.
PML participates in the regulation of p53 signaling, cell cycle progression, apoptosis, and cellular senescence. Through interactions with transcription factors, chromatin-associated proteins, and signaling regulators, it contributes to cellular responses to oncogenic stress and DNA damage. PML expression is also induced by interferon signaling, supporting its involvement in antiviral defense and immune-related stress responses. Nuclear body composition and organization can change following oxidative stress, viral infection, and other challenges, reflecting the protein's role in maintaining cellular homeostasis.
The PML gene is closely associated with acute promyelocytic leukemia, where a chromosomal translocation involving the retinoic acid receptor alpha gene produces the PML-RARA fusion protein. This fusion disrupts normal PML nuclear body organization and alters transcriptional programs controlling cell differentiation. Therapeutic targeting of PML-RARA promotes restoration of nuclear body structures and contributes to leukemia cell differentiation. Beyond hematologic malignancies, altered PML expression has been investigated in solid tumors, metabolic regulation, and aging-associated processes. Protein PML Antibody supports research into TRIM19 expression, nuclear body organization, and the molecular mechanisms connecting cellular stress responses with tumor suppression.
For complementary studies of PML expression and nuclear body regulation, our PML Antibody R32552 provides additional validation in human cell lysates and cancer tissues.
Optimal dilution of the Protein PML Antibody / TRIM19 Polyclonal Antibody should be determined by the researcher.
An E. coli-derived mouse protein (amino acids E107-A857) was used as the immunogen for the Protein PML antibody.
After reconstitution, the Protein PML antibody can be stored for up to one month at 4oC. For long-term, aliquot and store at -20oC. Avoid repeated freezing and thawing.
PML antibody, TRIM19 antibody, Promyelocytic leukemia protein antibody, Tripartite motif-containing protein 19 antibody, Promyelocytic leukemia nuclear body protein antibody, PML nuclear body protein antibody, PML tumor suppressor antibody, RING finger protein PML antibody, PML zinc finger protein antibody, PML protein antibody
Your bulk quote request has been submitted successfully!
Please contact us if you have any questions.